Pulmonary Embolism
58 drugs59,578 FAERS reportsMedDRA PT
GET
/api/v1/reaction/pulmonary-embolismReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D011655
Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
Source: U.S. National Library of Medicine — MeSH (Pulmonary Embolism)
Drugs reporting Pulmonary Embolism (58)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Ammonium Chloride8134%
- 2Manganese Sulfate2228%
- 3Epstein-barr Virus125%
- 4Butoconazole120%
- 5Fosamprenavir2519%
- 6Drospirenone9,51718%
- 7Levomefolate34318%
- 8Ethacrynate117%
- 9Ethinyl Estradiol13,85115%
- 10Taurolidine113%
- 11Azurite111%
- 12Cornsilk111%
- 13Titanium4310%
- 14Estradiol14,3567.6%
- 15Manganese236.1%
- 16Etonogestrel4,0645.9%
- 17Dalteparin5845.6%
- 18Fondaparinux4445.5%
- 19Nilutamide45.5%
- 20Lusutrombopag25.1%
- 21Methoxsalen374.9%
- 22Andexanet Alfa334.7%
- 23Argatroban694.7%
- 24Testosterone2,2464.3%
- 25Sodium Tetradecyl Sulfate24.1%
- 26Penicillin V984.0%
- 27Hepatitis B Immune Globulin23.9%
- 28Repotrectinib93.9%
- 29Ethiodized Oil483.8%
- 30Segesterone133.7%
- 31Canakinumab3873.6%
- 32Heparin4953.6%
- 33Estetrol83.6%
- 34Succinic Acid213.5%
- 35Mineral Oil1123.5%
- 36Vestronidase Alfa23.2%
- 37Baricitinib3023.2%
- 38Enoxaparin1,7973.2%
- 39Rivaroxaban5,9882.9%
- 40Polidocanol372.7%
- 41Megestrol1002.6%
- 42Cabazitaxel902.6%
- 43Factor Viia22.5%
- 44Apixaban1,5762.4%
- 45Leucovorin4442.4%
- 46Norgestimate1062.4%
- 47Saxagliptin322.2%
- 48Bivalirudin212.2%
- 49Chorionic Gonadotropin122.2%
- 50Tranexamic Acid1852.1%
- 51Amivantamab622.1%
- 52Raloxifene3302.1%
- 53Isatuximab1082.1%
- 54Temozolomide4192.0%
- 55Romiplostim2892.0%
- 56Thrombin71.8%
- 57Avatrombopag421.8%
- 58Medroxyprogesterone6821.3%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Deep Vein Thrombosis21 shared · 0.31
- Thrombosis18 shared · 0.29
- Haemorrhage11 shared · 0.11
- Metrorrhagia5 shared · 0.08
- Vaginal Haemorrhage5 shared · 0.07
- Injury6 shared · 0.07
- Menstruation Irregular4 shared · 0.06
- Ascites6 shared · 0.06
- General Physical Health Deterioration8 shared · 0.06
- Sepsis15 shared · 0.06
Literature
Recent PubMed references pinned to Pulmonary Embolism as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Aspirin Versus Direct Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Total Knee Arthroplasty: A 10-year Retrospective Cohort Study.Orthopedics · 2026 · Chi R, Fox K, Ewing B, et al.PMID 42206839DOI 10.3928/01477447-20260408-01
- Who labels best? Radiologists, rules, or large language models for CT reports on pulmonary embolism.European radiology experimental · 2026 · Fink MA, Bischoff A, Atsiatorme E, et al.PMID 42201590DOI 10.1186/s41747-026-00738-7
- HUCSR-Net: Automated Pulmonary Embolism Detection Using 3D Deep Learning.F1000Research · 2026 · Velandia C, Florez HPMID 42181902DOI 10.12688/f1000research.178627.1
- Concurrent bilateral adrenal haemorrhage and pulmonary emboli following emergency total hip replacement.BMJ case reports · 2026 · Rahman MR, Flowers D, Poulton S, et al.PMID 42173531DOI 10.1136/bcr-2025-269742
- Point-of-care ultrasound in hemodynamically unstable pulmonary embolism.Critical care (London, England) · 2026 · Moreno-Loaiza O, de Melo CB, Moreno-Loaiza M, et al.PMID 42169048DOI 10.1186/s13054-026-06097-4
- Comparison of aspirin and rivaroxaban for the prevention of pulmonary embolism and deep vein thrombosis in high thrombotic risk patients with systemic lupus erythematosus: study protocol for a multicentre, prospective, randomised controlled trial.Lupus science & medicine · 2026 · Zhang Z, Li F, Li Y, et al.PMID 42161432DOI 10.1136/lupus-2026-001981
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.